FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MG0J125

Delayed Börse Stuttgart 10:04:54 2024-06-07 am EDT
11.29 EUR +0.44% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+7.66%
1 month-2.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 11.29 +0.44%
24-06-06 11.24 +4.17%
24-06-05 10.79 +3.35%
24-06-04 10.44 -2.79%
24-06-03 10.74 +2.87%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 10:04 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG0J12
ISINDE000MG0J125
Date issued 2024-03-20
Strike 248.6 p
Maturity Unlimited
Parity 0.09 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.9
Lowest since issue 10.22
Spread 0.05
Spread %0.44%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.313 GBP
Average target price
3.646 GBP
Spread / Average Target
+10.07%
Consensus